Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,563 | -7,562 | -9,705 | -12,236 | -13,469 |
| Depreciation Amortization | 8 | 5 | 105 | 90 | 70 |
| Accounts receivable | -4 | -2 | 170 | -181 | -529 |
| Accounts payable and accrued liabilities | 309 | 122 | -801 | -370 | -131 |
| Other Working Capital | -1,736 | -1,056 | -2,353 | -537 | -1,698 |
| Other Operating Activity | 19 | 2,116 | -10,522 | -3,844 | -325 |
| Operating Cash Flow | $-12,967 | $-6,377 | $-23,106 | $-17,078 | $-16,082 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -7 | 893 | 893 | 900 |
| Investing Cash Flow | $-14 | $-7 | $893 | $893 | $900 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -35 | -35 | -35 |
| Other Financing Activity | 0 | 0 | 32,908 | 0 | 0 |
| Financing Cash Flow | $N/A | $N/A | $32,873 | $-35 | $-35 |
| Exchange Rate Effect | -5 | -3 | 1 | -9 | 0 |
| Beginning Cash Position | 47,657 | 47,657 | 36,996 | 36,996 | 36,996 |
| End Cash Position | 34,671 | 41,270 | 47,657 | 20,767 | 21,779 |
| Net Cash Flow | $-12,986 | $-6,387 | $10,661 | $-16,229 | $-15,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,967 | -6,377 | -23,106 | -17,078 | -16,082 |
| Capital Expenditure | -14 | -7 | -7 | -7 | 0 |
| Free Cash Flow | -12,981 | -6,384 | -23,113 | -17,085 | -16,082 |